相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Water, Health, and Environmental Justice in California: Geospatial Analysis of Nitrate Contamination and Thyroid Cancer
Arianna Q. Tariqi et al.
ENVIRONMENTAL ENGINEERING SCIENCE (2021)
Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes
Ildiko Lingvay et al.
POSTGRADUATE MEDICINE (2020)
Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials
Qian Lv et al.
DIABETES THERAPY (2020)
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin
Stefano Del Prato et al.
DIABETES OBESITY & METABOLISM (2018)
Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea
Kyoung Hwa Ha et al.
KOREAN CIRCULATION JOURNAL (2018)
Effect of metformin monotherapy on serum lipid profile in statin-naive individuals with newly diagnosed type 2 diabetes mellitus: a cohort study
Szu Han Lin et al.
PEERJ (2018)
Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study
Paul Chi Ho Lee et al.
DIABETES THERAPY (2018)
Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study
Paul Chi Ho Lee et al.
DIABETES THERAPY (2018)
Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly - A meta-analysis
Margit Solymar et al.
PLOS ONE (2018)
Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial
Ronald C. W. Ma et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial
Eirik Softeland et al.
DIABETES CARE (2017)
Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study
Julie C. Lauffenburger et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2017)
A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes
Seon-Ah Cha et al.
LIPIDS IN HEALTH AND DISEASE (2017)
FACTORS THAT INFLUENCE THERAPY IN PATIENTS WITH UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE
D. P. Pena et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes
Tao Xu et al.
DIABETES CARE (2015)
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
Ralph A. DeFronzo et al.
DIABETES CARE (2015)
Incretin physiology and pathophysiology from an Asian perspective
Young Min Cho
JOURNAL OF DIABETES INVESTIGATION (2015)
The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes
Tae Jung Oh et al.
CLINICAL ENDOCRINOLOGY (2014)
Body Composition Is the Main Determinant for the Difference in Type 2 Diabetes Pathophysiology Between Japanese and Caucasians
Jonas B. Moller et al.
DIABETES CARE (2014)
Ethnic-Specific Obesity Cutoffs for Diabetes Risk: Cross-sectional Study of 490,288 UK Biobank Participants
Uduakobong E. Ntuk et al.
DIABETES CARE (2014)
Metformin trims fats to restore insulin sensitivity
Reuben J. Shaw
NATURE MEDICINE (2013)
Adherence to Therapies in Patients with Type 2 Diabetes
Luis-Emilio Garcia-Perez et al.
DIABETES THERAPY (2013)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Effects of Ramadan Fasting on Biochemical and Hematological Parameters and Cytokines in Healthy and Obese Individuals
Murat Unalacak et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2011)
Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls
Daisuke Yabe et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Factors predicting hospital readmissions related to adverse drug reactions
Borja Ruiz et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Novel combination treatment of type 2 diabetes DPP-4 inhibition
Bo Ahren
VASCULAR HEALTH AND RISK MANAGEMENT (2008)
Epidemic obesity and type 2 diabetes in Asia
Kun-Ho Yoon et al.
LANCET (2006)
Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes
J Liu et al.
DIABETES CARE (2005)
分享论文
